The Fund Grade · free · no account needed
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Fidelity Value Fund
#238 of 500 graded active funds · value · mid segment peer group
The point · specialist footprint
FDVLX puts less of its book behind proven specialists than 80% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
FDVLX vs the Honor Roll · share card ↗Conviction exposure
5.7%
of the book in specialist-converged names
Late-stage weight
27.2%
of the book in Crowded or Fading names
Active share
92.8%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Fidelity Value Fund grades C, ranking 238 of 500, with only 5.7% specialist backing, a sign that proven active money has limited conviction here. Over a quarter of the portfolio sits in late-stage positions, and names like PCG, APO, and EQIX are actively being exited by specialists. The early bright spots are DAL, TRGP, and UPS, but they are small weights.
→ Watch PCG, APO, and EQIX closely, specialists are leaving all three and they total roughly 3% of the fund.
→ Higher graded funds exist in the same Fidelity family and in this segment, worth comparing before staying put.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.